Nanopatch Delivery of DNA-Based Malaria Vaccines to Skin: Precisely Targeting the Skin Immune System for Radically Improved Vaccines

Mark Kendall of the University of Queensland in Australia will design and test nanopatches, small patches consisting of microscopic silicon projections coated with a malaria vaccine in dry form, to target immunologically-sensitive cells within the skin's outer layers - that are missed by the needle and syringe - to induce unique and protective immune response against the disease.